New lanostanoids from Ganoderma lucidum that induce NAD(P)H : quinone oxidoreductase in cultured hepalclc7 murine hepatoma cells

Citation
Tbt. Ha et al., New lanostanoids from Ganoderma lucidum that induce NAD(P)H : quinone oxidoreductase in cultured hepalclc7 murine hepatoma cells, PLANTA MED, 66(7), 2000, pp. 681-684
Citations number
25
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PLANTA MEDICA
ISSN journal
00320943 → ACNP
Volume
66
Issue
7
Year of publication
2000
Pages
681 - 684
Database
ISI
SICI code
0032-0943(200010)66:7<681:NLFGLT>2.0.ZU;2-6
Abstract
Two new lanostanoids were isolated from the basidiocarp of Ganoderma lucidu m and were identified as 26,27-dihydroxy-5 alpha -lanosta-7,9(11),24-triene -3,22-dione (1) and 26-hydroxy-5 alpha -lanosta-7,9(11),24-triene-3,22-dion e (2) by their respective spectral data. Crude extracts and the isolated co mpounds were tested for their potential to induce NAD(P)H:quinone oxidoredu ctase (QR), a phase 2 drug-metabolizing enzyme, as an approach to detect po tential cancer chemopreventive activity. Compound 2 doubled the specific ac tivity of QR at a concentration of 3.0 mug/ml, whereas compound 1 was signi ficantly less active (1.7-fold induction at 20 mug/ml). In addition, both c ompounds weakly inhibited sheep vesicle cyclooxygenase 1 activity at a test concentration of 40 mug/ml.